The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic
Isabelle Boutron
(1, 2)
,
Anna Chaimani
(1, 2)
,
Joerg Meerpohl
(3, 4)
,
Asbjørn Hróbjartsson
(5, 6)
,
Declan Devane
(7, 8)
,
Gabriel Rada
(9, 10)
,
David Tovey
(11)
,
Giacomo Grasselli
(12)
,
Philippe Ravaud
(1)
,
Covid Nma Consortium
1
CRESS (U1153 / UMR_A 1125) -
Centre for Research in Epidemiology and Statistics | Centre de Recherche Épidémiologie et Statistiques
2 Cochrane France
3 University of Freiburg [Freiburg]
4 German Cochrane Centre, University Medical Centre Freiburg
5 SDU - University of Southern Denmark
6 Odense University Hospital
7 NUI Galway - National University of Ireland [Galway]
8 Cochrane Ireland
9 UC - Pontificia Universidad Católica de Chile
10 Cochrane Chile
11 Cochrane France
12 UNIMI - Università degli Studi di Milano = University of Milan
2 Cochrane France
3 University of Freiburg [Freiburg]
4 German Cochrane Centre, University Medical Centre Freiburg
5 SDU - University of Southern Denmark
6 Odense University Hospital
7 NUI Galway - National University of Ireland [Galway]
8 Cochrane Ireland
9 UC - Pontificia Universidad Católica de Chile
10 Cochrane Chile
11 Cochrane France
12 UNIMI - Università degli Studi di Milano = University of Milan
Anna Chaimani
- Fonction : Auteur
- PersonId : 784783
- ORCID : 0000-0003-2828-6832
Philippe Ravaud
- Fonction : Auteur
- PersonId : 756868
- ORCID : 0000-0001-8264-9206
- IdRef : 060251395
Covid Nma Consortium
- Fonction : Auteur
Résumé
These authors propose an “evidence ecosystem” for COVID-19–related studies that minimizes multiple low-quality reviews and helps connect evidence generation, synthesis, and decision making.